Medicated bone scaffolds processed by a combined solvent-free method based on supercritical foaming and thermal porogen leaching in Polymers Journal

Accidental and bone-diseases related fractures have a particular impact in the wellness and mobility of elderly people, leading to devastating physical and mental consequences that preclude the possibility of recovering the preceding welfare status of the patient. The advent of the regenerative medicine field facilitated the development of synthetic biodegradable grafts, known as scaffolds, offering a promising outlook for the full recovery of bone functionality.

Among the manufacturing techniques for the preparation of polymeric scaffolds, the supercritical CO2-assisted foaming offers significant advantages regarding the solvent-free processability of materials and the loading of bioactive compounds in an integrated process and at high yields. However, the technique has limitations regarding the complex modelling of the pore formation mechanisms to get a precise control and predictability of the pore sizes and distributions obtained for the processed scaffolds.

In this work, an innovative processing approach was developed to obtain drug-loaded scaffolds by supercritical foaming coupled with solid porogen removal. The absence of solvents required for the removal of the porogen agent (ammonium bicarbonate) avoids the leaching of the drug. Overall, this solvent-free technology opens up a variety of possibilities of tuning porosity and pore sizes in medicated scaffolds through the porogen features.

The work entitled “Solvent-Free Processing of Drug-Loaded Poly(ε-Caprolactone) Scaffolds with Tunable Macroporosity by Combination of Supercritical Foaming and Thermal Porogen Leaching” has been published in Polymers journal.